Xepi

Active Ingredient(s): Ozenoxacin
FDA Approved: * December 11, 2017
Pharm Company: * FERRER INTERNACIONAL
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Xepi Overview

Ozenoxacin (INN; trade names Ozaenex and Xepi) is a quinolone antibiotic being approved for the treatment of impetigo.[1] A 1% topical cream is approved for treatment of impetigo in Canada[2] and in the United States.[3] Ozenoxacin is active against some bacteria that have developed resistance to currently used quinolone and fluoroquinolone antibiotics.[4] References ^ "Ferrer successfully completes a phase III clinical trial in adult and paediatric patients with impetigo for novel antib...

Read more Xepi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ozenoxacin

Recent Xepi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Xepi: (1 result)

Sorted by National Drug Code

• 43538-320 Xepi 10 mg/g Topical Cream by Medimetriks Pharmaceuticals, Inc.

Other drugs which contain Ozenoxacin or a similar ingredient: (2 results)